| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 4,622,000 | 4,517,000 | 4,554,000 | 5,032,000 | | Cost of Revenue | 1,519,000 | 1,610,000 | 1,916,000 | 2,071,000 | | | Gross Profit | 3,103,000 | 2,907,000 | 2,638,000 | 2,961,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,272,000 | 1,386,000 | 1,369,000 | 1,202,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 401,000 | 398,000 | 374,000 | 408,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,430,000 | 1,123,000 | 895,000 | 1,351,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (40,000) | (58,000) | 236,000 | 118,000 | | Earnings Before Interest And Taxes | 1,382,000 | 1,060,000 | 1,114,000 | 1,449,000 | | Interest Expense | 215,000 | 221,000 | 212,000 | 211,000 | | Income Before Tax | 1,167,000 | 839,000 | 902,000 | 1,238,000 | | Income Tax Expense | 418,000 | 258,000 | 339,000 | 459,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 749,000 | 581,000 | 563,000 | 779,000 | | | Non-recurring Events | | Discontinued Operations | (1,000) |
-
|
-
| 1,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 748,000 | 581,000 | 563,000 | 780,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $748,000 | $581,000 | $563,000 | $780,000 |
|
1.49% Nasdaq 
0.27%
Income Statement
